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A comparative study of the bell-bottom technique
vs hypogastric exclusion for the treatment of
aneurysmal extension to the iliac bifurcation
Peter A. Naughton, MD,a,b Michael S. Park, MD,a Elrasheid A. H. Kheirelseid, MD,b
Sean M. O’Neill, MD,b Heron E. Rodriguez, MD,a Mark D. Morasch, MD,a Prakash Madhavan, MD,b
and Mark K. Eskandari, MD,a Chicago, Ill; and Dublin, Ireland
Introduction: A significant proportion of patients undergoing endovascular aneurysm repair (EVAR) have common iliac
artery aneurysms (CIAA). Aneurysmal involvement at the iliac bifurcation potentially undermines long-term durability.
Methods: Patients with CIAA who underwent EVAR were identified in two teaching hospitals. Bell-bottom technique
(BBT; iliac limb>20 mm) or internal iliac artery embolization and limb extension to the external iliac artery (IIE EE)
were used. Outcome between these two approaches was compared.
Results: We identified 185 patients. Indication for EVAR included asymptomatic abdominal aortic aneurysm (AAA) in
157, symptomatic or ruptured aneurysm in 19, and CIAA in nine. Mean AAA diameter was 59 mm. Among 260 large
CIAAs that were treated, BBT was used to treat 166 CIAA limbs, and 94 limbs underwent IIEEE. Total reintervention
rates were 11% for BBT (n  19) and 19.1% for IIE  EE (n  18; P  .149). Rates of reintervention for type Ib or III
endoleak were 4% for BBT (n  7) and 4% for IIE  EE (n  4; P > .99). The difference in limb patency rates was not
significant. The 30-day mortality rate was 1%. Median follow-up was 22 months. Complications did not differ
significantly between the two groups; however, the combined incidence of perioperative complications and reinterven-
tions was higher in the IIE  EE group (49% vs 22%; P  .002).
Conclusions: The combined incidence of perioperative complications and reinterventions is significantly higher with
IIE  EE than with BBT; therefore, when feasible, BBT is desirable. ( J Vasc Surg 2012;55:956-62.)
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aEndovascular abdominal aortic aneurysm (AAA) repair
(EVAR) has evolved as a feasible, less invasive alternative to
open repair.1-3 Limiting the long-term complications spe-
cific to EVAR is a challenge to interventionalists. Poor
patient or stent graft selection undermines the effectiveness
of EVAR.4 Various preoperative, intraoperative, and post-
operative factors may compromise repair. To date, most
studies report the outcome of EVAR in patients with
adverse morphologic features at the proximal seal, includ-
ing neck angulation, diameter, and thrombus.5-7 Postoper-
ative aortic remodeling after successful sac exclusion and
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956ate progression of aneurysmal degeneration may predis-
ose to late endoleaks.8,9
The common iliac artery (CIA) serves as the distal stent
raft implantation site. Concomitant CIA aneurysms
CIAAs) are present in 15% to 40% of patients with AAA.10
s with the proximal landing zone, a durable distal seal is
ssential. Alternatively, deploying additional stent grafts
nto external iliac arteries (EIA) may compromise long-
erm stent graft patency.11 There are conflicting results on
hether concomitant ectasis or CIAA limits full exclusion
f the aneurysm and increases the complexity of
VAR.10-14 A variety of open and endovascular techniques
re available to treat these patients. In the absence of many
omparative studies, standardization of treatment is
oor.15,16 The two most commonly performed procedures
re internal iliac embolization (IIE) or occlusion with stent
raft extension to the EIA extension (IIE  EE) and the
ared limb or bell-bottom technique (BBT) to the CIA.
he present study compared the outcomes of these two
pproaches.
ETHODS
A retrospective review was performed of all patients
ho underwent EVAR in two large university teaching
ospitals, Northwestern Memorial Hospital (NMH),
hicago, Illinois, and St. James’s Hospital (SJH), Dub-
in, Ireland, between January 2004 and December 2009.
MH and SJH are high-volume vascular centers with an
nnual caseload of 50 EVARs, and 350 EVARs have
een performed in each institution since their endovas-
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EVAR with an iliac stent graft diameter 20 mm (BBT)
or IIE  EE were identified from a prospectively col-
lected database documenting demographics, presenta-
tion, procedure, and outcome. Data collection was per-
formed according to approved Institutional Review
Board protocols.
A preinterventional computed tomography angiogram
(CTA) with intravenous contrast and multiplanar recon-
struction was used in all patients to assess the extent of
aneurysmal disease, tortuosity of the iliac vessels, and pa-
tency of the internal and EIA. All EVARs were completed
in the operating angiography suite equipped with a fixed
fluoroscopic unit. EVAR was performed under general
anesthesia in 122 patients, spinal anesthesia in 58, or local
anesthesia in five. Access was achieved by entirely percuta-
neous access using the suture-mediated closure “preclose”
technique in 65 patients (35%); the remaining patients
needed cutdown femoral artery exposure.17
In the IIE  EE group, embolization was performed
preferentially via a contralateral approach before EVAR.
The technique used depended on anatomy and operator
preference. IIE was achieved using an Amplatzer vascular
plug (AGA Medical, Golden Valley, Minn) delivered
though an appropriately sized guiding sheath or by
0.035-inch coils (MR Eye or Nestor Coils, Cook Medi-
cal Inc, Bloomington, Ind) delivered through a selection
of 5F to 6F catheters. The internal iliac artery (IIA) was
occluded at the origin except when the presence of an
internal iliac artery aneurysm precluded flush occlus-
ion and proximal embolization; in these circumstances,
the primary branches of the internal iliac artery were
embolized.
Initially, the BBT involved deploying an aortic exten-
Table I. Patient demographics
Variables a
Total
(N  260)
Characteristics
Age 73  8.1
AAA diameter, mm 59.2  14
Male sex 243 (93.5)
Comorbidities
Hypertension 196 (75.7)
COPD 22 (8.5)
Diabetes 36 (13.9)
Smoking 88 (34.2)
Hyperlipidemia 147 (56.8)
Ischemic heart disease 107 (41.2)
Renal disease 6 (2.3)
Outcome
30-day mortality 2 (1.1)
Reinterventions  complications 51 (28.3)
AAA, Abdominal aortic aneurysm; BBT, bell-bottom technique; COPD, ch
and limb extension to the external iliac artery.
aData are presented as mean  standard deviation or number (%).
bStudent t test.
c2 Test or Fisher exact test.sion cuff or a reverse-mounted iliac limb stent graft in the distal CIA landing zone using techniques previously de-
cribed.16,18 Recently, this technique has been superseded
y the introduction of commercially available large-diame-
er iliac extension limbs of up to 28-mm diameter.19
Follow-up. During the postoperative period, the pa-
ient’s progress was closely monitored and complications
oted by the operating team. Acute renal failure (ARF) was
efined as any increase in the creatinine level3.0 mg/dL,
ith or without the need for dialysis. Respiratory failure was
efined as postoperative pneumonia, respiratory insuffi-
iency, or prolonged intubation. Myocardial infarction was
efined by at least two of the following criteria: typical chest
ain lasting 20 minutes; serum levels of creatine kinase,
reatine kinase-MB, or troponin at least twice the upper
imit of the normal range; and new Q wave on at least two
djacent derivations or predominant R waves in V1 (R wave
1 mm S wave in V1). Clinically significant hematoma
as defined as any hematoma that prolonged hospital stay
r necessitated reintervention.
All patients had clinical examination and CTA at 1
onth and annually thereafter in NMH. In SJH, duplex
ltrasound scanning with selective CTA surveillance was
erformed as previously validated.20
Statistics. Normally distributed continuous data are
xpressed as mean  standard deviation (SD), and median
interquartile range) is used to describe the non-normally
istributed continuous data. Student t tests were used, as
ppropriate, for comparison of continuous variables, and
he 2 test was used for analysis of categoric variables. All
ests were two-sided and a result was considered significant
f the calculated P value was .05. SPSS 18.0 software
SPSS Inc, Chicago, Ill) was used for statistical analysis.
ifferences in limb patency and rate of type Ib/III en-
BBT IIE  EE
P(n  166) (n  94)
72.7  8.0 73.5  8.4 .468b
59.5  13.3 58.6  16 .627b
156 (94) 87 (92.6) .656c
119 (72.1) 77 (81.9) .077c
18 (10.8) 4 (4.3) .067c
18 (10.9) 18 (19.1) .065c
58 (35.2) 30 (32.6) .680c
96 (58.2) 51 (34.3) .540c
74 (44.6) 33 (35.1) .136c
3 (1.8) 3 (3.2) .475c
2 (1.7) 0 (0) .286c
26 (22) 25 (49) .002
obstructive pulmonary disease; IIE  EE, internal iliac artery embolizationronicoleak between the two groups were determined with
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testing.
RESULTS
Demographics. Among the 185 patients treated with
EVAR, 260 concomitant large CIAs were treated. Mean
age was 73 8.1 years and 93.5% were men. Demograph-
ics and comorbid conditions were similar between the BBT
and IIE  EE groups (Table I).
Procedural results. EVAR and CIAA exclusion was
achieved using a number of commercially available stent
graft devices: 107 had Excluder (W. L. Gore & Assoc,
Flagstaff, Ariz); 67 had Talent or Endurant (Medtronic,
Minneapolis, Minn), 56 had Zenith (Cook Medical Inc,
Bloomington, Ind), and 26 had other devices (AneuRx
[Medtronic], Ancure, [Guidant, Indianapolis, Ind] and
Endologix [Irvine, Calif]).
BBT was used to treat 166 patients (64%), and 94 (36%)
underwent IIE  EE. Interestingly, a higher proportion of
patients treated with the Excluder device were treated by
IIE EE (52%) compared with Talent/Endurant (18%) or
Zenith (19%; P  .0001; Table II). IIE was completed
using an Amplatzer vascular plug in 41, coils in 47, and a
combination of coils and plug in six.
In two patients with bilateral CIAAs, an EIA–IIA by-
Fig 1. Reintervention rates in our cohort of patients.
Table II. Type of stent-graft device used in the two
treatment groups
Type of stent
BBT IIE  EE
No. (%) No. (%)
Cook 46 (82.1) 10 (17.9)
Medtronic 57 (85.1) 10 (14.9)
Gore 51 (47.7) 56 (52.3)
Others 12 (46.2) 14 (53.8)
BBT, Bell-bottom technique; COPD, chronic obstructive pulmonary dis-
ease; IIE  EE, internal iliac artery embolization and limb extension to the
external iliac artery.pass was performed before bilateral IIE. Both patients were Ioung, active men who opted for this additional procedure
o preserve pelvic perfusion rather than undergo staged
IE. An additional patient who underwent IIE was noted to
ave a tight stenosis at the origin of the contralateral IIA
hat was treated with angioplasty and deployment of a
alloon-expandable stent at the time of EVAR. The average
istal limb diameter in the BBT group was 20 mm (range,
0-28 mm).
Perioperative complications. The overall complica-
ion rate was 28%. Although not statistically significant,
ore procedure-specific, access-related, and general com-
lications were noted in the internal iliac artery emboliza-
ion group than in the BBT group.
The specific complication rate was 9% in the BBT group
nd 10.6% in the IIE  EE group (P  .674). Specific
omplications reported in the IIE  EE patients included
uttock claudication (2.1%), limb occlusion (1.1%), and
elvic ischemia (1.1%); whereas complications in BBT pa-
ients included kinked limb (0.6%) and limb occlusion
2.4%). When the IIE  EE group was further analyzed,
ore specific complications were noted in patients who
nderwent bilateral embolization compared with those
ho had unilateral artery embolization (38.5% vs 6.2%; P
001).
Analysis of access-related complications showed no sig-
ificant difference between the two groups (11.7% in IIE
E vs 7.2% in BBT; P  .222). Hematoma was the most
ommon access-related complication (6.4% in IIE  EE
nd 6% in BBT). In addition, 5.4% of access-related prob-
ems were wound pain and infection in IIE EE compared
ith 1.8% in BBT group.
General complications included acute myocardial in-
arction in three, acute renal failure in two, nonspecific
owel conditions (pain, diarrhea) in three, respiratory tract
nfection in six, and urinary tract infection in one. No
ignificant difference was noted in general complications
hen the groups were compared (15.7% in BBT vs 25.5% in
ig 2. Overall reinterventions comparing the bell-bottom tech-
ique (BBT) with internal iliac artery embolization (IIE).IE  EE; P  .052).
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Volume 55, Number 4 Naughton et al 959There were only two 30-day mortalities. Both of these
patients (one from each treatment group, 1.1%) presented
with ruptured AAA.
Reintervention. Median follow-up was 22 months
(interquartile range, 9-38 months). Overall reintervention
rate was 14%: 11 patients (4%) had reintervention for a type
Ib or III endoleak and seven (3%) to maintain iliac limb
patency (Fig 1). Comparison of outcomes in the BBT
patients with the IIE  EE group found no significant
difference in total reintervention (11.6% vs 19%; P  .15;
Fig 2), type Ib or III endoleak (4% vs 4%; P .888; Fig 3),
or limb patency (3% vs 2%; P  .566; Fig 4). Subgroup
analysis found no difference in outcome in the BBT group
treated with 20- or 22-mm diameter iliac limbs (n  146)
compared with IIE  EE who were treated with 24- or
28-mm limbs (n  20; P  .05).
DISCUSSION
EVAR is based on the successful exclusion of blood
flow into the aneurysmal sac. A significant number of
patients undergoing EVAR have concomitant CIAAs.
These CIAAs may undermine the benefit of EVAR if a
robust distal seal is not achieved. Patients with CIAA may
have unfavorable anatomic features and more extensive
Fig 3. Reintervention for type Ib/III endoleaks comp
internal iliac embolization (IIE).medical comorbidities.13 aThe importance of the distal seal zone is highlighted in
hree large, single-center studies examining reintervention
fter EVAR.21-23 Problems at the distal landing zone were
more common indication for reintervention than proxi-
al seal compromise in all three studies. Mehta et al23
eport the largest single-center experience of EVAR (n 
768) with a reintervention rate of 19.2%. Progressive IAA
ormation was the third most common indication for rein-
ervention (11.5%), and 7.4% of reinterventions were for
liac limb thrombosis. Iliac limb occlusion was the second
ost common indication for reintervention in a series of
32 EVAR patients.22 In our experience of endovascular
eintervention after EVAR, type Ib endoleak was the most
ommon indication for reintervention.4
Few studies focus on the outcome of patients with
oncomitant CIAA during EVAR and results are conflict-
ng.10,12-14 Increased complexity of procedure, AAA-
elated complications, and reinterventions are reported in
hree studies.12-14 Hobo et al13 (n  6668) report that
hose with concomitant CIAA had a higher incidence of
ype Ib endoleaks, iliac limb occlusion, reinterventions, and
neurysm rupture. Albertini et al12 had similar results in
atients with CIAA extending to the distal third of the CIA.
IAA renders EVAR more complex with longer operative
large iliac repair with bell-bottom technique (BBT) vsaringnd fluoroscopic time and more contrast used.14 In con-
I
p
n
e
i
t
a
e
s
s
e
c
c
w
T
a
d
i
C
d
E
t
JOURNAL OF VASCULAR SURGERY
April 2012960 Naughton et altrast, the Cook Zenith trial (n  736) failed to show any
significant difference in technical success, AAA-related
complications, or reintervention in patients with concomi-
tant CIAA.10 CIA expansion developed in 30% of patients;
this enlargement was not related to the baseline diameter of
CIA but to stent graft oversizing.
A number of techniques are available to treat patients
with concomitant CIAA during EVAR. Options include
IIE  EE, BBT, iliac side-branch device, open advance-
ment of the CIA bifurcation by internal iliac artery bypass/
transposition, and aortouniiliac stent graft with femoral–
femoral bypass with a retrograde endovascular EIA–IIA
bypass.24-32 In the absence of randomized controlled stud-
ies, standardization of treatment is poor.
Patient anatomy, operator preference, availability of
appropriate stent graft, and financial constraints influence
the technique adopted. IIE  EE and BBT are the two
most commonly performed procedures. In our earlier ex-
perience, there was preference to perform IIE  EE, but
with the introduction of commercially available larger iliac
limbs, BBT was often favored when anatomically feasible.
Anatomic factors favoring IIE EE included CIA bifurca-
tion 25 mm, significant thrombus in the CIA, or the
presence of aneurysm of the IIA. Factors favoring BBT
Fig 4. Limb patency comparing large iliac repair using
(IIE).included contralateral IIA occlusion and CIA of 25 mm. Tschemic complications caused by coil misplacement or
elvic malperfusion limit the appeal of IIE  EE.33-35 A
umber of strategies devised to diminish this risk of isch-
mia by preserving the pelvic collateral vascular network
nclude interruption of the IIA as proximally as possible,
hereby preserving the IIA bifurcation; preferential use of
n Amplatzer vascular plug with its deployment system,
nabling accurate positioning of occlusion at the target site;
taging IIE before EVAR; and taking precautions to pre-
erve the contralateral IIA.36 However, there is emerging
vidence that these measures fail to diminish the ischemic
omplications of IIE.18,37 In view of the unpredictability of
omplications, techniques to preserve IIA flow should al-
ays be considered.
BBT facilitates a distal seal while preserving pelvic flow.
his technique has been facilitated by commercially avail-
ble large-diameter iliac extension limbs. The long-term
urability of deploying large diameter iliac extension limbs
nto a CIAA is uncertain because data on the progression of
IA diameter after open AAA repair show that growth is
irectly proportional to the baseline diameter.38
The present study is the first study to compare IIE 
E with BBT. In this series, low rates of reintervention for
ype Ib/III endoleak and iliac limb patency are reported.
bottom technique (BBT) to internal iliac embolizationbell-here was no significant difference in reintervention be-
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higher combined incidence of perioperative complications
and long-term reintervention. Similar to Kirkwood et al,10
use of large iliac limbs in BBT was not associated with
increased risk of type Ib endoleaks. In the absence of
noninferiority of BBT and lower complications, these re-
sults suggest that BBT may be preferable to IIE  EE
because it preserves pelvic flow.
This study has a number of limitations: First, it is
retrospective; therefore, we are unable to analyze all factors
that contributed to the decision of technique adopted to
treat concomitant CIAAs, and furthermore, analysis of all
the anatomic factors that contributed to treatment failure is
limited.
Second, combining two centers’ experience risks com-
paring heterogenous patient groups and interventionalists.
Analysis failed to demonstrate significant differences in
patient demographics or treatment outcome between the
two centers.
Finally, with low incidence of reintervention and treat-
ment failure, perhaps greater patient numbers and longer
follow-up may reveal differences between the treatment
groups. In addition, certain complications like buttock
claudication may be more accurately assessed via prospec-
tively recorded quality of life studies.
CONCLUSIONS
This is the first reported study comparing IIE  EE
with BBT in patients undergoing EVAR with concomitant
CIAA. Both treatment groups had low rates of reinterven-
tion. There was no significant difference in the incidence of
distal endoleaks or iliac limb patency. BBT preserves pelvic
perfusion and has a lower incidence of combined compli-
cations and reintervention. A multicenter randomized
study is appropriate but present results support the prefer-
ence of BBT when feasible.
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